IL166054A0 - Novel compounds pharmaceutical compositions containing same and methods of use for same - Google Patents
Novel compounds pharmaceutical compositions containing same and methods of use for sameInfo
- Publication number
- IL166054A0 IL166054A0 IL16605403A IL16605403A IL166054A0 IL 166054 A0 IL166054 A0 IL 166054A0 IL 16605403 A IL16605403 A IL 16605403A IL 16605403 A IL16605403 A IL 16605403A IL 166054 A0 IL166054 A0 IL 166054A0
- Authority
- IL
- Israel
- Prior art keywords
- same
- methods
- pharmaceutical compositions
- compositions containing
- novel compounds
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/26—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D307/30—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/32—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/26—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D307/30—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/32—Oxygen atoms
- C07D307/33—Oxygen atoms in position 2, the oxygen atom being in its keto or unsubstituted enol form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/58—One oxygen atom, e.g. butenolide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Child & Adolescent Psychology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Furan Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US39280902P | 2002-07-01 | 2002-07-01 | |
| PCT/US2003/020960 WO2004006835A2 (fr) | 2002-07-01 | 2003-07-01 | Nouveaux composes, compositions pharmaceutiques les contenant et leurs procedes d'utilisation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL166054A0 true IL166054A0 (en) | 2006-01-15 |
Family
ID=30115535
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL16605403A IL166054A0 (en) | 2002-07-01 | 2003-07-01 | Novel compounds pharmaceutical compositions containing same and methods of use for same |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US20060241177A1 (fr) |
| EP (1) | EP1534263A4 (fr) |
| JP (1) | JP2005533107A (fr) |
| KR (1) | KR20050072670A (fr) |
| CN (2) | CN100482219C (fr) |
| AU (1) | AU2003248810B2 (fr) |
| BR (1) | BRPI0312413A2 (fr) |
| CA (1) | CA2491183A1 (fr) |
| EA (1) | EA010484B1 (fr) |
| IL (1) | IL166054A0 (fr) |
| MX (1) | MXPA05000152A (fr) |
| SG (1) | SG170620A1 (fr) |
| WO (1) | WO2004006835A2 (fr) |
| ZA (1) | ZA200500203B (fr) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9018737D0 (en) * | 1990-08-28 | 1990-10-10 | Goodfellow John W | Phosphetic patellar components |
| MXPA04007556A (es) | 2002-02-08 | 2005-12-05 | Univ Johns Hopkins Med | Estimulacion de cpt-1 como medio para reducir peso. |
| US20060135568A1 (en) * | 2002-07-09 | 2006-06-22 | Townsend Craig A | Methods of treating microbial infections in humans and animals |
| CN101007796A (zh) * | 2006-01-27 | 2007-08-01 | 北京摩力克科技有限公司 | 新型五元杂环化合物及其制备方法和医疗用途 |
| CN101190904A (zh) * | 2006-11-23 | 2008-06-04 | 中国人民解放军军事医学科学院毒物药物研究所 | 脂肪酸合成酶抑制剂及其制药用途 |
| WO2009023059A2 (fr) | 2007-06-01 | 2009-02-19 | The Trustees Of Princeton University | Traitement d'infections virales par modulation de voies métaboliques de cellules hôtes |
| WO2010118324A2 (fr) | 2009-04-09 | 2010-10-14 | Nuclea Biotechnologies, LLC | Anticorps dirigés contre la synthase des acides gras |
| FR2957078B1 (fr) * | 2010-03-05 | 2012-05-04 | Centre Nat Rech Scient | Acides paraconiques comme activateurs de pigmentation |
| US8450350B2 (en) | 2010-05-05 | 2013-05-28 | Infinity Pharmaceuticals, Inc. | Triazoles as inhibitors of fatty acid synthase |
| CA2798330A1 (fr) | 2010-05-05 | 2011-11-10 | Infinity Pharmaceuticals, Inc. | Tetrazolones utilises en tant qu'inhibiteurs d'acide gras synthase (fasn) |
| WO2014039769A1 (fr) * | 2012-09-07 | 2014-03-13 | Janssen Pharmaceutica Nv | Dérivés d'imidazoline—5-one utiles en tant qu'inhibiteurs de l'acide gras synthase (fasn) pour le traitement du cancer |
| CN103145662B (zh) * | 2013-02-18 | 2014-07-16 | 深圳万和制药有限公司 | N-取代的氨基丁内酯衍生物及其用途 |
| CN103864731B (zh) * | 2014-02-19 | 2016-01-20 | 成都中医药大学 | 含季碳手性中心的呋喃内酯环类化合物的合成方法 |
| CN104530018B (zh) * | 2014-12-12 | 2017-04-12 | 郑州大学 | 含α‑亚甲基‑γ‑丁内酯结构的吲哚类化合物、制备方法及其应用 |
| WO2016126973A1 (fr) * | 2015-02-05 | 2016-08-11 | Dermira Inc. | Procédé de synthèse pour la préparation de 5-tétradécyloxy)furan-2-carboxylate de 2-((2-éthoxy-2-oxoéthyl)(méthyl)amino)-2-oxoéthyle |
| KR102038971B1 (ko) * | 2018-03-12 | 2019-11-26 | 주식회사 엔지켐생명과학 | 디아실글리세롤락톤 화합물, 그 제조방법 및 이를 유효성분으로 함유하는 면역증진제 |
| KR102755466B1 (ko) | 2021-05-26 | 2025-01-21 | 울산과학기술원 | 미토콘드리아 표적화 뉴클레오펩티드 및 이를 포함하는 암의 예방 또는 치료용 약학적 조성물 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3496187A (en) * | 1967-03-20 | 1970-02-17 | American Home Prod | N-(heterocyclyl)aconamides |
| US3472878A (en) * | 1969-01-27 | 1969-10-14 | American Home Prod | N-(hydroxyaryl)aconamides |
| US4753871A (en) * | 1986-12-12 | 1988-06-28 | Eastman Kodak Company | Cyan dye-forming couplers and photographic materials containing same |
| JPS63169848A (ja) * | 1987-01-07 | 1988-07-13 | Nec Corp | デジタルデ−タ通信におけるデ−タ端末収容方式 |
| JP2524760B2 (ja) * | 1987-07-10 | 1996-08-14 | テイカ株式会社 | 新規抗生物質 |
| JPH04199148A (ja) * | 1990-11-29 | 1992-07-20 | Konica Corp | ハロゲン化銀写真感光材料 |
| JPH05246822A (ja) * | 1992-03-07 | 1993-09-24 | Nippon Paint Co Ltd | 抗菌剤 |
| JPH07112931A (ja) * | 1993-08-27 | 1995-05-02 | Nippon Paint Co Ltd | エプスタイン−バーウイルス活性化抑制剤 |
| EP0869784B1 (fr) * | 1995-11-17 | 2005-08-31 | The Johns Hopkins University | Inhibition de synthase d'acide gras destinee a reduire la masse adipocyte |
| DE60028996T2 (de) * | 1999-11-12 | 2007-02-08 | The Johns Hopkins University School Of Medicine | Behandlung von krebs durch erhöhung des malonyl-coa-spiegels |
| WO2001060174A2 (fr) * | 2000-02-16 | 2001-08-23 | The Johns Hopkins University School Of Medicine | Perte de poids induite par la reduction du niveau de neuropeptide y |
-
2003
- 2003-07-01 IL IL16605403A patent/IL166054A0/xx unknown
- 2003-07-01 WO PCT/US2003/020960 patent/WO2004006835A2/fr not_active Ceased
- 2003-07-01 SG SG200806631-8A patent/SG170620A1/en unknown
- 2003-07-01 CN CNB038183692A patent/CN100482219C/zh not_active Expired - Fee Related
- 2003-07-01 EA EA200500122A patent/EA010484B1/ru not_active IP Right Cessation
- 2003-07-01 AU AU2003248810A patent/AU2003248810B2/en not_active Ceased
- 2003-07-01 ZA ZA200500203A patent/ZA200500203B/xx unknown
- 2003-07-01 BR BRPI0312413A patent/BRPI0312413A2/pt not_active IP Right Cessation
- 2003-07-01 JP JP2004521521A patent/JP2005533107A/ja active Pending
- 2003-07-01 US US10/519,804 patent/US20060241177A1/en not_active Abandoned
- 2003-07-01 KR KR1020047021601A patent/KR20050072670A/ko not_active Ceased
- 2003-07-01 MX MXPA05000152A patent/MXPA05000152A/es not_active Application Discontinuation
- 2003-07-01 CN CN200910126506A patent/CN101633650A/zh active Pending
- 2003-07-01 EP EP03764343A patent/EP1534263A4/fr not_active Withdrawn
- 2003-07-01 CA CA002491183A patent/CA2491183A1/fr not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| JP2005533107A (ja) | 2005-11-04 |
| HK1086485A1 (zh) | 2006-09-22 |
| AU2003248810A1 (en) | 2004-02-02 |
| WO2004006835A3 (fr) | 2004-07-22 |
| BRPI0312413A2 (pt) | 2016-08-02 |
| WO2004006835A2 (fr) | 2004-01-22 |
| MXPA05000152A (es) | 2005-10-24 |
| CA2491183A1 (fr) | 2004-01-22 |
| CN1705478A (zh) | 2005-12-07 |
| SG170620A1 (en) | 2011-05-30 |
| AU2003248810B2 (en) | 2009-08-20 |
| US20060241177A1 (en) | 2006-10-26 |
| KR20050072670A (ko) | 2005-07-12 |
| EA200500122A1 (ru) | 2005-12-29 |
| CN101633650A (zh) | 2010-01-27 |
| EP1534263A4 (fr) | 2006-10-11 |
| EA010484B1 (ru) | 2008-10-30 |
| ZA200500203B (en) | 2009-09-30 |
| EP1534263A2 (fr) | 2005-06-01 |
| CN100482219C (zh) | 2009-04-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL166108A0 (en) | Novel compounds pharmaceutical compositions containing same and methods of use for same | |
| IL173639A0 (en) | Ppar-activating compound and pharmaceutical composition containing same | |
| IL164987A0 (en) | Proline derivatives and pharmaceutical compositions containing | |
| IL173930A0 (en) | Pharmaceutical compositions containing forms of r-baclofen | |
| HUP0400974A3 (en) | Peptide-based compounds and pharmaceutical compositions containing them | |
| IL164455A0 (en) | Heterocyclic compounds and pharmaceutical compositions containing the same | |
| HUP0401711A3 (en) | N-heterocyclic inhibitors of tnf-alpha and pharmaceutical compositions containing them | |
| IL164185A0 (en) | Pharmaceutical compositions containing trifluoromethylphenyl amide derivatives | |
| HUP0401333A3 (en) | Spiropyrazole compounds and pharmaceutical compositions containing them | |
| IL174128A0 (en) | Heterocyclic compounds and pharmaceutical compositions containing the same | |
| HUP0302485A3 (en) | Arylmethylamine derivatives for use as tryptase inhibitors and pharmaceutical compositions containing them | |
| IL219396A0 (en) | Compounds for the treatment of metabolic disorders and pharmaceutical compositions containing same | |
| AU2002363236A1 (en) | Compounds, pharmaceutical compositions and methods of use therefor | |
| HUP0302412A3 (en) | Betha-carboline derivatives useful as inhibitors of phosphodiesterase and pharmaceutical compositions containing the same | |
| HUP0400384A3 (en) | Benzamidine derivative and pharmaceutical compositions containing them and their use | |
| HUP0303724A3 (en) | Chemokine receptors inhibitor bipiperidinyl-derivatives and pharmaceutical compositions containing them and process for preparation of the compounds | |
| HUP0303193A3 (en) | Phthalayinone-piperidino-derivatives as pde4 inhibitors and pharmaceutical compositions containing them | |
| SI1664050T1 (sl) | Nevroprotektične biciklične spojine in farmacevtski sestavki, vsebujoči le-te | |
| IL164022A0 (en) | Phosphate derivatives of fluoroxindole and pharmaceutical compositions containing the same | |
| HRP20041079A2 (en) | Novel perindopril salt and pharmaceutical compositions containing same | |
| IL166621A0 (en) | Polymorph of n-methyl-n-(3-ä-3-Ä2-thienylcarbonylÜ-pyrazol-Ä1,5-alphaÜpyrimidin-7-ylüacetamide and pharmaceutical compositions containing the same | |
| ZA200500203B (en) | Novel compounds, pharmaceutical compositions containing same, and methods of use for same | |
| IL174249A0 (en) | Heterocyclic compounds and pharmaceutical compositions containing the same | |
| PL367128A1 (en) | Chemical compounds and pharmaceutical compositions as cathepsin s inhibitors | |
| ZA200508204B (en) | Pharmaceutical composition of atorvastatin |